Particle.news

RKI: Moderate Respiratory Activity, Officials Urge Targeted Vaccinations

Health agencies recommend single‑visit co‑administration of influenza, RSV, pneumococcal and COVID‑19 vaccines for older and at‑risk people to reduce severe illness.

Overview

  • In late October the Robert Koch Institute assessed respiratory illness as moderate and said a nationwide influenza wave has not started, based on sentinel, laboratory and wastewater data.
  • The Ständige Impfkommission updated 2026 guidance that prioritizes influenza shots for people aged 60 and older, RSV and pneumococcal vaccines for older and high‑risk patients, and COVID‑19 boosters mainly for those 75 and older or with specific risk conditions.
  • Local health offices, including Fürstenfeldbruck, have joined a national information campaign and advise that up to four vaccines can be given at one appointment to simplify protection for vulnerable groups.
  • Clinics and pharmacies report rising patient volumes and demand for masks and tests, and clinicians are combining vaccination appeals with basic prevention advice such as fresh air, handwashing, sleep and nutrition.
  • Vaccine uptake varies regionally, with some areas showing below‑average rates and others like Tirol reporting higher orders and no expected supply shortages, which could affect local pressure on practices and the timing of a possible seasonal wave.